Evaluation of the Onset of Flea-Killing Activity of a Monthly Oral Formulation Containing Sarolaner, Moxidectin, Pyrantel, and R-Praziquantel in Naturally Infested Dogs
Effectiveness, tolerability, and residual effect of a sarolaner-based chewable tablet for the treatment and control of ticks in naturally infested canines
Effectiveness, tolerability, and residual effect of a sarolaner-based chewable tablet for the treatment and control of fleas in naturally infested canines
Safety assessment of a monthly sarolaner-based chewable tablet in canines
Evaluation of the onset time of flea-killing activity of a monthly oral formulation based on sarolaner in canines
Palatability evaluation of a sarolaner-based chewable tablet in canines
Palatability evaluation of a soft tablet based on fluralaner, moxidectin and praziquantel1 administered quarterly in canines.
Evaluation of the comparative efficacy of Halocox® G Px as an anticoccidial in broiler chickens when administered in feed